Crinetics Pharmaceuticals' Pizzuti Dana buys, sells shares at $16.89, $45.02.

Crinetics Pharmaceuticals, Inc. (CRNX) recently disclosed that Dana Pizzuti, the company's Chief Medical and Development Officer, executed a transaction involving the purchase and sale of shares on December 1, 2025. Specifically, Pizzuti purchased 5,000 shares at a price of $16.89 per share, and subsequently sold an equal number of shares at $45.02 per share on the same day.